Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
Number | Exp. Date | Activity Code(s) | Title Sort descending |
---|---|---|---|
PAR-24-144 | January 8, 2027 | R16 | Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) |
NOT-OD-23-125 | January 1, 2027 | Technical and Business Assistance (TABA) Consulting Services for National Institutes of Health (NIH) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II or Phase IIB Awardees | |
NOT-MH-13-011 | January 1, 2027 | Technical Assistance for the Development of High Throughput Screening (HTS) Assay | |
NOT-MH-21-310 | January 1, 2027 | The BRAIN Initiative Plan for Enhancing Diverse Perspectives (PEDP) | |
NOT-HD-12-035 | January 1, 2027 | The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Announces the Creation of Two New Branches to Better Facilitate NICHD Research Priorities | |
NOT-HD-09-013 | January 1, 2027 | The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will not participate in NOT-OD-09-058 NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications | |
NOT-HD-08-006 | January 1, 2027 | The National Children's Study NCS Environmental Sample Analytical Laboratories | |
NOT-HD-05-013 | January 1, 2027 | The National Institute of Child Health and Human Development Consortium on Safe Labor | |
NOT-HD-07-013 | January 1, 2027 | The National Standard for Normal Fetal Growth | |
PAR-21-305 | January 10, 2025 | R01 | Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) |
PAR-22-233 | March 2, 2025 | R61/R33 | Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed) |
RFA-OD-22-009 | July 2, 2024 | R01 | Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) |
PAR-23-130 | May 8, 2026 | R01 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) |
PAR-23-131 | May 8, 2026 | R21 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) |
RFA-OD-23-014 | June 21, 2024 | R01 | Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional) |
RFA-OD-23-013 | June 21, 2024 | R21 | Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional) |
PAR-24-059 | January 8, 2027 | R01 | Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional) |
NOT-HD-16-010 | January 1, 2027 | Updated Application Forms (FORMS-D) Available for PAR-16-106 "Rapid Assessment of Zika Virus (ZIKV) Complications (R21)" on May 25, 2016 | |
NOT-HD-05-009 | January 1, 2027 | Updated Information and Clarification: RFA-HD-04-025 - Adolescent Medicine Trials Network for HIV/AIDS Interventions | |
NOT-HD-05-008 | January 1, 2027 | Updated Information and Clarification: RFA-HD-05-018 Pediatric HIV/AIDS Cohort Study (PHACS) |